Navigation Links
Lupin Receives Final Approval to Market Generic Ultram® ER
Date:8/31/2011

BALTIMORE, Aug. 31, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) today announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200 and 300 mg strengths.   Lupin will begin shipping its Tramadol ER shortly.

Tramadol HCl ER is a centrally acting synthetic analgesic in an extended release formulation.  It is the generic equivalent to Ortho-McNeil's Ultram®* ER Tablets and is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.  Tramadol HCl ER tablets had annual sales of approximately $132 million for the twelve months ended June 2011 based on IMS Health sales data.

About Lupin

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs. The Company today has significant market share in Cardiovasculars, Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs in addition holding global leadership positions in the Anti-TB and Cephalosporins space.  

Today, Lupin is the 5th largest and fastest growing generics player in the US (by prescriptions), the only Asian company to achieve that distinction.   The company is also the fastest growing top 10 pharmaceutical player in India, Japan and South Africa. (IMS Health)

For the financial year ended March 2011, Lupin's Consolidated Revenues and Profit after Tax were Rs.57,068 million USD 1.28 Billion) and Rs. 8,626  million (USD 193 million)  respectively.  Please visit http://www.lupinworld.com for more information about Lupin Ltd.

Lupin Pharmaceuticals, Inc. is t
'/>"/>

SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lupin Expands Branded Play
2. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
3. HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
4. Lupin Announces Launch of Generic Levaquin® Tablets
5. Lupin Launches Additional Strengths of Generic Lotrel® Capsules
6. Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
11. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... 28, 2015 Recent Highlights: ... first patient in PerClot ® IDE ... device and tissue processing company focused on cardiac and ... quarter of 2015.  Pat Mackin, Chairman, ... significant milestones regarding two of our top organizational objectives.  ...
(Date:4/28/2015)... BERLIN , April 28, 2015 ... universities of Berlin and the ... Berlin as a central research location ... of scientific, technical and medical information products and services, ... Charité, the Humboldt University (Humboldt-Universität), the Free University ...
(Date:4/28/2015)... 28, 2015  Influential proxy advisory firm Institutional ... at Gilead Sciences, a shareholder proposal asking the ... management and mitigation of the business risks associated ... of rapidly increasing U.S. drug prices and efforts ... costs. Proposal 8, Stockholder ...
Breaking Medicine Technology:CryoLife Reports First Quarter Results 2CryoLife Reports First Quarter Results 3CryoLife Reports First Quarter Results 4CryoLife Reports First Quarter Results 5CryoLife Reports First Quarter Results 6CryoLife Reports First Quarter Results 7CryoLife Reports First Quarter Results 8CryoLife Reports First Quarter Results 9Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 2Elsevier and the Friedrich-Althoff Consortium Collaborate to Create "Archive of Berlin" as a Basis for a Common Research Infrastructure 3ISS Recommends Shareholders Vote For Specialty Drug Pricing Risk Assessment Proposal At Gilead Sciences 2ISS Recommends Shareholders Vote For Specialty Drug Pricing Risk Assessment Proposal At Gilead Sciences 3
(Date:4/28/2015)... 2015 The biologics safety testing market ... for the market include growth of the pharmaceutical and ... launches. Over the years, the number of drug approvals ... 2010, the FDA approved 225 drug applications and Health ... accounted for 3,822 of the pharmaceutical and 1,998 of ...
(Date:4/28/2015)... 2015 An Allegheny Health Network ... MD, FACS , has launched the first U.S. clinical ... matrix (ECM) can help patients who are at high ... , ECM is a complex mixture of naturally-occurring polymers ... and signals that guide cell behavior. ECM, manufactured from ...
(Date:4/28/2015)... Culver City, CA (PRWEB) April 28, 2015 ... today in the Journal of Molecular Imaging and ... with [18F]DCFPyL, a 2nd generation fluorine-18 labeled small-molecule ... at Johns Hopkins University in Baltimore, MD by ... , “This initial human evaluation of [18F]DCFPyL demonstrated ...
(Date:4/28/2015)... April 28, 2015 The buyer power ... out of 5, indicating a medium level of buyer ... and suppliers have equal power during negotiations. One factor ... than purchasing a health insurance policy from an insurance ... Humana), buyers can choose to self-fund their own policy ...
(Date:4/28/2015)... (PRWEB) April 28, 2015 Wimbledon ... which provides vascular, electrocardiogram, echocardiogram, and NCV testing, ... vascular testing to help podiatrists diagnose peripheral arterial ... to diagnose PAD without the aid of vascular ... Medical Officer at Wimbledon Health Partners. “Diminished ...
Breaking Medicine News(10 mins):Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 2Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 3Health News:Biological Safety Testing Market, By Application Product & Test – Global Forecast 2019 - Report Released by MarketsandMarkets 4Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 2Health News:Allegheny Health Network Launches First U.S. Clinical Trial of Extracellular Matrix as Replacement for Pre-Cancerous Tissue 3Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 2Health News:Second Generation 18F-labeled Prostate-Specific Membrane Antigen (PSMA) Targeted Imaging Agent Found to be Highly Sensitive in Detecting Prostate Cancer 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 2Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 3Health News:New Data for Group Health Insurance Procurement Category Market Research Report from IBISWorld 4Health News:Podiatrists Affiliate with Wimbledon Health Partners to Diagnose Peripheral Arterial Disease 2
... to Laurus Fully Repaid, LARGO, Fla., Oct. ... DYHP.OB) ("Dynamic"), a leading distributor in,the sports nutrition ... filed its Articles of Merger with the Florida ... of its merger with GeoPharma, Inc.,(Nasdaq: GORX ...
... Oct. 15 Speaker Nancy Pelosi,issued the following ... override,President Bush,s veto of the State Children,s Health ... in the House who have not already joined,this ... their vote,and to stand with 10 million children ...
... MINNEAPOLIS, Oct. 15 The Health Care,Compliance Association ... important compliance concerns for hospitals and for physicians,outlined ... Services Office of,Inspector General (OIG) 2008 Work Plan. ... industry., This vital two-part audio/web conference will ...
... Also Renews Commitment to Darfur, STAMFORD, Conn., Oct. ... more than $7,billion in aid to people in need ... AmeriCares President and CEO Curt Welling announced the milestone ... held at Westchester County Airport on Saturday., "I ...
... addition to Masimo Rainbow SET platform seen as having,potential clinical ... ... FRANCISCO, Oct. 15 Masimo, the inventor,of Pulse CO-Oximetry and ... independent and objective clinical study,presented today at the 2007 American ...
... of motion, study found , MONDAY, Oct. 15 ... and after surgery, helped reduce pain and promote mobility ... finding was presented Sunday at the annual meeting of ... The study, funded by drug maker Pfizer Inc., included ...
Cached Medicine News:Health News:Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma 2Health News:Dynamic Files Articles of Merger; Notifies Nasdaq of Merger with GeoPharma 3Health News:Critical HCCA Web/Audio Conference Will Review Office of Inspector General Compliance Concerns Outlined in FY 2008 Work Plan 2Health News:AmeriCares Passes $7 Billion Mark in Aid Distributed 2Health News:Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume 2Health News:Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume 3Health News:Breaking Study: Masimo Pleth Variability Index (PVI) Shown Effective in Noninvasive Detection of Changes in Ventricular Preload and Fluid Volume 4Health News:Anti-Convulsant Aids Knee-Replacement Patients 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: